Cargando…

Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial

Detalles Bibliográficos
Autores principales:	Lopiano, Leonardo, Alberto Artusi, Carlo, Bozzali, Marco, Ancidoni, Antonio, Ciccone, Giovannino, De Rosa, Francesco, Vanacore, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498354/ http://dx.doi.org/10.1016/j.jns.2021.119884

Ejemplares similares

Neurological comorbidity and severity of COVID-19
por: Romagnolo, Alberto, et al.
Publicado: (2020)

Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations?
por: Artusi, Carlo Alberto, et al.
Publicado: (2023)

Efficacy of oral amantadine among patients hospitalised with COVID-19: A randomised, double-blind, placebo-controlled, multicentre study
por: Barczyk, Adam, et al.
Publicado: (2023)

COVID-19 and Parkinson’s Disease: What Do We Know So Far?
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Amantadine for COVID-19 treatment (ACT study): a randomized, double-blinded, placebo-controlled clinical trial
por: Weis, Nina, et al.
Publicado: (2023)

Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)

Cohort study of neurological comorbidities and COVID-19-related case fatality
por: Imbalzano, Gabriele, et al.
Publicado: (2021)

Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
por: Montanaro, Elisa, et al.
Publicado: (2021)

Neurological comorbidities and COVID-19-related case fatality: A cohort study
por: Romagnolo, Alberto, et al.
Publicado: (2021)

Time to onset and duration of botulinum toxin efficacy in movement disorders
por: Ledda, Claudia, et al.
Publicado: (2022)

Intravenous Amantadine for Freezing of Gait Resistant to Dopaminergic Therapy: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial
por: Kim, Young Eun, et al.
Publicado: (2012)

A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment
por: Cohen, Jeffrey A, et al.
Publicado: (2021)

Responder analyses for anti-amyloid immunotherapies for Alzheimer’s disease: a paradigm shift by regulatory authorities is urgently needed
por: Salemme, Simone, et al.
Publicado: (2023)

Editorial: Advances in Functional Neurosurgery
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection
por: Piazza, Federico, et al.
Publicado: (2021)

Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations
por: Romagnolo, Alberto, et al.
Publicado: (2023)

Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report
por: Bozzali, Marco, et al.
Publicado: (2021)

Raw Water and ALS: A Unifying Hypothesis for the Environmental Agents Involved in ALS
por: Stipa, Giuseppe, et al.
Publicado: (2023)

Assessment of Axial Postural Abnormalities in Parkinsonism: Automatic Picture Analysis Software
por: Artusi, Carlo Alberto, et al.
Publicado: (2023)

COVID-19 in Parkinson's disease: Report on prevalence and outcome
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)

Burden of caregiving for cardiovascular dysautonomia in Parkinson’s disease
por: Ledda, Claudia, et al.
Publicado: (2022)

The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial
por: Sadeqi, Yasaman, et al.
Publicado: (2022)

Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
por: Nguyen, Jack T., et al.
Publicado: (2012)

Anti-dementia drugs: a descriptive study of the prescription pattern in Italy
por: Ippoliti, Ilaria, et al.
Publicado: (2023)

Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial
por: Bo, Simona, et al.
Publicado: (2018)

Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation
por: Aldegheri, Stefano, et al.
Publicado: (2023)

Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
por: Zhao, Ying, et al.
Publicado: (2021)

Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease
por: Montanaro, Elisa, et al.
Publicado: (2021)

SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials
por: Lacorte, Eleonora, et al.
Publicado: (2022)

The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial
por: Movahed, Ali, et al.
Publicado: (2016)

Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study
por: Marinelli, Lucio, et al.
Publicado: (2022)

Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study
por: Mollace, Rocco, et al.
Publicado: (2022)

Amantadine, COVID-19 and Parkinsonism
por: Wiwanitkit, Viroj
Publicado: (2020)

Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury
por: Shafiee, Sajad, et al.
Publicado: (2022)

Protocol for Escitalopram and Language Intervention for Subacute Aphasia (ELISA): A randomized, double blind, placebo-controlled trial
por: Stockbridge, Melissa D., et al.
Publicado: (2021)

A double-blinded, placebo-controlled, randomized study to evaluate the efficacy of perioperative dextromethorphan compared to placebo for the treatment of postoperative pain: a study protocol
por: Jones, Ian A., et al.
Publicado: (2023)

Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial
por: Sun, Yuanlong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o5g8k9j7ogiqd5vkcn9rs3on9q